| Literature DB >> 29090643 |
Luisa Z Moreno1, Carlos E C Matajira1, Andre P Poor1, Renan E Mesquita1, Vasco T M Gomes1, Ana Paula S Silva1, Cristina R Amigo1, Ana Paula G Christ2, Mikaela R F Barbosa2, Maria Inês Z Sato2, Andrea M Moreno1.
Abstract
BACKGROUND: Urinary tract infection (UTI) is a common disease in sows due to intensification of pig production. Despite direct economic losses, UTI prevalence and respective microbial identification are still poorly studied.Entities:
Keywords: MALDI-TOF; Porcine; antimicrobial resistance; infection; swine; urine
Mesh:
Substances:
Year: 2018 PMID: 29090643 PMCID: PMC6830825 DOI: 10.1080/01652176.2017.1397302
Source DB: PubMed Journal: Vet Q ISSN: 0165-2176 Impact factor: 3.320
Infection characterization of studied urine samples with characteristics suggestive of urinary tract infection.
| Herd | ||||
|---|---|---|---|---|
| Bacterial infection | H1 | H2 | H3 | |
| One species | 62 (48,4) | 17 (54.8) | 28 (38.9) | 17 (68.0) |
| Two species | 39 (30.5) | 9 (29.1) | 24 (33.3) | 6 (24.0) |
| Three species | 25 (19.5) | 5 (16.1) | 18 (25.0) | 2 (8.0) |
| Four species | 2 (1.6) | 0 | 2 (2.8) | 0 |
| Total | 128 (100) | 31 (100) | 72 (100) | 25 (100) |
Bacterial species associated with single urinary infection.
| Herd | ||||
|---|---|---|---|---|
| Species | H1 | H2 | H3 | |
| 44 (71.0) | 6 (35.3) | 23 (82.1) | 15 (88.2) | |
| 6 (9.7) | 6 (35.3) | – | – | |
| 3 (4.8) | 2 (11.8) | – | 1 (5.9) | |
| 2 (3.2) | – | 1 (3.6) | 1 (5.9) | |
| 2 (3.2) | 1 (5.9) | 1 (3.6) | – | |
| 1 (1.6) | – | 1 (3.6) | – | |
| 1 (1.6) | 1 (5.9) | – | – | |
| 1 (1.6) | – | 1 (3.6) | – | |
| 1 (1.6) | – | 1 (3.6) | – | |
| 1 (1.6) | 1 (5.9) | – | – | |
| Total | 62 (100) | 17 (100) | 28 (100) | 17 (100) |
Figure 1.Mixed infections cluster analysis with identification and characterization of infection profiles. The colors indicate the herd of origin (green – H2, red – H1, blue – H3).
In vitro resistance rates of Gram-negative pathogens (N = 116) – N (%).
| Antimicrobial | Susceptible | Intermediary | Resistant |
|---|---|---|---|
| Amoxicillin/clavulanic acid | 99 (85.3) | 15 (12.9) | 2 (1.7) |
| Ampicillin | 31 (26.7) | 1 (0.9) | 84 (72.4) |
| Ceftiofur | 102 (87.9) | 11 (9.5) | 3 (2.6) |
| Sulfadimethoxine | 1 (0.9) | 4 (3.4) | 111 (95.7) |
| Trimethoprim/ sulpham | 31 (26.7) | 3 (2.6) | 82 (70.7) |
| Tetracycline | 15 (12.9) | 10 (8.6) | 91 (78.4) |
| Norfloxacin | 70 (60.3) | 12 (10.3) | 34 (29.3) |
| Enrofloxacin | 35 (30.2) | 27 (23.3) | 54 (46.6) |
| Ciprofloxacin | 63 (54.3) | 24 (20.7) | 29 (25.0) |
| Florfenicol | 15 (12.9) | 3 (2.6) | 98 (84.5) |
| Spectinomycin | 85 (73.3) | 11 (9.5) | 20 (17.2) |
| Streptomycin | 12 (10.3) | 45 (38.8) | 59 (50.9) |
Trimethoprim/sulphamethoxazole.
Gram-negative pathogens resistance profile distribution according to the number of resistant antimicrobial classes.
| Resistance profile | ||||
|---|---|---|---|---|
| Species | 1 - 2 classes | 3 - 4 classes | ≥ 5 classes | Total |
| - | 3 (100) | - | 3 (100) | |
| 1 (25.0) | 3 (75.0) | - | 4 (100) | |
| 1 (50.0) | 1 (50.0) | - | 2 (100) | |
| 1 (20.0) | 4 (80.0) | - | 5 (100) | |
| 2 (2.0) | 42 (42.0) | 56 (56.0) | 100 (100) | |
| - | 1 (100) | - | 1 (100) | |
| - | 1 (100) | - | 1 (100) | |
| Total | 5 (4.3) | 55 (47.4) | 56 (48.3) | 116 (100) |
Figure 2.Resistance profiles cluster analysis of studied Gram-negative pathogens. The grey scale (black, grey and white) corresponds to resistant, intermediate and sensitive status, respectively. The colored squares indicate the different Gram-negative bacterial species.
In vitro resistance rates of Gram-positive pathogens (N = 108) – N (%).
| Antimicrobial | Susceptible | Intermediary | Resistant |
|---|---|---|---|
| Penicillin | 59 (54.6) | 6 (5.6) | 43 (39.8) |
| Ampicillin | 60 (55.5) | 3 (2.8) | 45 (41.7) |
| Ceftiofur | 60 (55.5) | 6 (5.6) | 42 (38.9) |
| Tetracycline | 52 (48.1) | 6 (5.6) | 50 (46.3) |
| Enrofloxacin | 42 (38.9) | 16 (14.8) | 50 (46.3) |
| Sulfadimethoxine | 79 (73.1) | 3 (2.8) | 26 (24.1) |
| Trimet/sulfamet | 65 (60.2) | 1 (0.9) | 42 (38.9) |
| Florfenicol | 50 (46.3) | 12 (11.1) | 46 (42.6) |
| Clindamycin | 57 (52.8) | 13 (12.0) | 38 (35.2) |
| Gentamycin | 46 (42.6) | 3 (2.8) | 59 (54.6) |
| Neomycin | 55 (50.9) | 3 (2.8) | 50 (46.3) |
| Spectinomycin | 55 (50.9) | 18 (16.7) | 35 (32.4) |
| Tylosin | 39 (36.1) | – | 69 (63.9) |
Trimethoprim/sulfamethoxazole.
Gram-positive pathogens resistance profile distribution according to the number of resistant antimicrobial classes.
| Resistance profile | ||||
|---|---|---|---|---|
| Species | 1–2 classes | 3–4 classes | ≥5 classes | Total |
| – | 7 (31.8) | 15 (68.2) | 22 (100) | |
| – | 1 (100) | – | 1 (100) | |
| – | 1 (100) | – | 1 (100) | |
| – | 1 (50.0) | 1 (50.0) | 2 (100) | |
| – | 1 (100) | – | 1 (100) | |
| 1 (20.0) | 4 (80.0) | – | 5 (100) | |
| 4 (36.4) | – | – | 11 (100) | |
| 6 (66.7) | 3 (33.3) | – | 9 (100) | |
| – | 1 (100) | – | 1 (100) | |
| 3 (100) | – | – | 3 (100) | |
| 1 (50.0) | 1 (50.0) | – | 2 (100) | |
| 1 (50.0) | – | 1 (50.0) | 2 (100) | |
| – | 1 (100) | – | 1 (100) | |
| – | 7 (63.6) | 4 (36.4) | 11 (100) | |
| – | 1 (100) | – | 1 (100) | |
| – | – | 1 (100) | 1 (100) | |
| – | 3 (75.0) | 1 (25.0) | 4 (100) | |
| – | – | 1 (100) | 1 (100) | |
| – | – | 2 (100) | 2 (100) | |
| – | – | 2 (100) | 2 (100) | |
| – | – | 1 (100) | 1 (100) | |
| – | – | 10 (100) | 10 (100) | |
| – | – | 4 (100) | 4 (100) | |
| – | 3 (37.5) | 5 (62.5) | 8 (100) | |
| – | – | 2 (100) | 2 (100) | |
| Total | 16 (14.8) | 35 (32.4) | 50 (46.3) | 108 (100) |
Figure 3.Resistance profiles cluster analysis of studied Gram-positive pathogens. The grey scale (black, grey and white) corresponds to resistant, intermediate and sensitive status, respectively. The colored squares indicate the detected resistance groups (red – A, orange – B, blue – C).